Back to News
Market Impact: 0.15
Jetstream Venture Fund Invests in Rejuvenation Technologies, Expanding its Expanding Longevity and Regenerative Medicine Portfolio
Source: PR Newswire
Private Markets & VentureHealthcare & Biotech
Jetstream Venture Fund announced a strategic investment in Rejuvenation Technologies, expanding its interval-fund portfolio of institutional-style private-market deal flow. The announcement does not disclose the investment amount, valuation, or expected financial impact, limiting its likely relevance to broader markets.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion
- CorMedix stock gains as Heron deal adds four products
- Rezolute at Guggenheim: FDA progress lifts rare-disease hopes
- Hims & Hers earnings up next: Can GLP-1 boom drive profit?
- Harrow earnings on deck as investors eye profitability return